Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Jazz Pharmaceuticals, Inc.](/topic/$jazz)

### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% no change  
**6 Months**: XXX% +46%  
**1 Year**: XXX% +35%  
**1-Year High**: XXX% on 2025-02-20  
**1-Year Low**: XX% on 2025-02-01  

**Most Supportive Themes**
- **Positive Regulatory News and Approvals:** (35%) Posts highlight positive regulatory events, such as FDA approvals for generic versions of Jazz Pharmaceuticals' drugs.
- **Analyst Recommendations and Price Targets:** (25%) Mentions of analyst ratings and price targets, which can influence investor sentiment and trading activity.
- **Product Pipeline and Clinical Trials:** (20%) Positive mentions of Jazz Pharmaceuticals' product pipeline, including Modeyso (dordaviprone) and its inclusion in NCCN guidelines.
  
**Most Critical Themes**
- **Competition and Market Dynamics:** (20%)  Mentions of competition in the narcolepsy market, such as Avadel's Lumryz, and the impact on Jazz Pharmaceuticals' market share.
- **Earnings Miss and Financial Performance:** (10%)  The company faced a miss in earnings expectations, with non-GAAP EPS of $1.68, which could be a concern for investors.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %    | Negative | %  |
| ------- | -------- | -  | ------- | -    | -------- | -  |
| TikTok  | XX       | X% | XXXXXX  | XX%  | X        | X% |
| X       | XX       | X% | XXX     | X%   | X        | X% |
| Reddit  | XX       | X% | X       | X%   | X        | X% |
|         |          |    |         |      |          |    |
| Total   | XX       | X% | XXXXXX  | XXX% | X        | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Jazz Pharmaceuticals, Inc.

Sentiment: XXX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% no change
6 Months: XXX% +46%
1 Year: XXX% +35%
1-Year High: XXX% on 2025-02-20
1-Year Low: XX% on 2025-02-01

Most Supportive Themes

  • Positive Regulatory News and Approvals: (35%) Posts highlight positive regulatory events, such as FDA approvals for generic versions of Jazz Pharmaceuticals' drugs.
  • Analyst Recommendations and Price Targets: (25%) Mentions of analyst ratings and price targets, which can influence investor sentiment and trading activity.
  • Product Pipeline and Clinical Trials: (20%) Positive mentions of Jazz Pharmaceuticals' product pipeline, including Modeyso (dordaviprone) and its inclusion in NCCN guidelines.

Most Critical Themes

  • Competition and Market Dynamics: (20%) Mentions of competition in the narcolepsy market, such as Avadel's Lumryz, and the impact on Jazz Pharmaceuticals' market share.
  • Earnings Miss and Financial Performance: (10%) The company faced a miss in earnings expectations, with non-GAAP EPS of $1.68, which could be a concern for investors.

Network engagement breakdown:

Network Positive % Neutral % Negative %
TikTok XX X% XXXXXX XX% X X%
X XX X% XXX X% X X%
Reddit XX X% X X% X X%
Total XX X% XXXXXX XXX% X X%
Jazz Pharmaceuticals, Inc. (JAZZ) Sentiment
/topic/$jazz/sentiment